Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7

Oncogene

Volumn 25, Issue 44, 2006, Pages 5953-5959

  Ohlenschlager O ^a   Seiboth, T ^a   Zengerling, H ^a   Briese, L ^a,d   Marchanka, A ^a   Ramachandran, R ^a   Baum, M ^a   Korbas, M ^b   Meyer Klaucke, W ^b   Durst M ^c   Gorlach M ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d General Electrics   (Germany)

Author keywords

Carcinogenesis; E7; Human papilloma virus; NMR solution structure

Indexed keywords

AMIDE; CELL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN E7; ZINC;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; BINDING AFFINITY; BINDING SITE; BIOLOGICAL MONITORING; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CONTROLLED STUDY; DIMERIZATION; HUMAN PAPILLOMAVIRUS 45; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; UTERINE CERVIX CANCER; VIRUS TYPING; WART VIRUS;

AMINO ACID SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIMERIZATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN FOLDING; RISK FACTORS; SOLUTIONS; ZINC FINGERS;

HUMAN PAPILLOMAVIRUS;

EID: 33747153263     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209584     Document Type: Article

References (43)

1. Alonso LG, Garcia-Alai MM, Nadra AD, Lapena AN, Almeida FL, Gualfetti P et al. (2002). Biochemistry 41: 10510-10518.
2. Avvakumov N, Torchia J, Mymryk JS. (2003). Oncogene 22: 3833-3841.
3. Barbosa MS, Edmonds C, Fisher C, Schiller JT, Lowy DR, Vousden KH. (1990). EMBO J 9: 153-160.
4. Barbosa MS, Lowy DR, Schiller JT. (1989). J Virol 63: 1404-1407.
5. Bartels C, Xia T, Billeter M, Guntert P, Wuthrich K. (1995). J Biomol NMR 6: 1-10.
6. Binsted N, Strange RW, Hasnain SS. (1992). Biochemistry 31: 12117-12125.
7. Bischof O, Nacerddine K, Dejean A. (2005). Mol Cell Biol 25: 1013-1024.
8. Bosch FX, de Sanjose S. (2003). J Natl Cancer Inst Monogr 31: 3-13.
9. Braspenning J, Marchini A, Albarani V, Levy L, Ciccolini F, Cremonesi C et al. (1998). Oncogene 16: 1085-1089.
10. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ et al. (1999). EMBO J 18: 2449-2458.
11. Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE. (2001). Nat Struct Biol 8: 833-837.
12. Clements A, Johnston K, Mazzarelli JM, Ricciardi RP, Marmorstein R. (2000). Biochemistry 39: 16033-16045.
13. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. (2004). Virology 324: 17-27.
14. Dotto GP. (2000). Biochim Biophys Acta 1471: M43-M56.
15. Dyson HJ, Wright PE. (2005). Nat Rev Mol Cell Biol 6: 197-208.
16. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. (1997). Genes Dev 11: 2090-2100.
17. Goodwin EC, DiMaio D. (2000). Proc Natl Acad Sci USA 97: 12513-12518.
18. Gorlach M, Wittekind M, Beckman RA, Mueller L, Dreyfuss G. (1992). EMBO J 11: 3289-3295.
19. Gulbis JM, Kelman Z, Hurwitz J, O'Donnell M, Kuriyan J. (1996). Cell 87: 297-306.
20. Guntert P, Billeter M, Ohlenschlager O, Brown LR, Wuthrich K. (1998). J Biomol NMR 12: 543-548.
21. Guntert P, Mumenthaler C, Wuthrich K. (1997). J Mol Biol 273: 283-298.
22. Helt AM, Funk JO, Galloway DA. (2002). J Virol 76: 10559-10568.
23. Herrmann T, Guntert P, Wuthrich K. (2002). J Mol Biol 319: 209-227.
24. Jones DL, Alani RM, Munger K. (1997). Genes Dev 11: 2101-2111.
25. Koradi R, Billeter M, Wuthrich K. (1996). J Mol Graph 14: 51-55.
26. Kriwacki RW, Hengst L, Tennant L, Reed SI, Wright PE. (1996). Proc Natl Acad Sci USA 93: 11504-11509.
27. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. (1996). J Biomol NMR 8: 477-486.
28. Lee JO, Russo AA, Pavletich NP. (1998). Nature 391: 859-865.
29. Liu X, Clements A, Zhao K, Marmorstein R. (2006). J Biol Chem 281: 578-586.
30. Mannhardt B, Weinzimer SA, Wagner M, Fiedler M, Cohen P, Jansen-Durr P et al. (2000). Mol Cell Biol 20: 6483-6495.
31. McIntyre MC, Frattini MG, Grossman SR, Laimins LA. (1993). J Virol 67: 3142-3150.
32. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M et al. (2004). J Virol 78: 11451-11460.
33. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M et al. (2001). Oncogene 20: 7888-7898.
34. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. (1989). J Virol 63: 4417-4421.
35. Phelps WC, Munger K, Yee CL, Barnes JA, Howley PM. (1992). J Virol 66: 2418-2427.
36. Schlott B, Wohnert J, Icke C, Hartmann M, Ramachandran R, Guhrs KH et al. (2002). J Mol Biol 318: 533-546.
37. Singh M, Krajewski M, Mikolajka A, Holak TA. (2005). J Biol Chem 280: 37868-37876.
38. Villa LL. (1997). Adv Cancer Res 71: 321-341.
39. Vuister GW, Bax A. (1993). J Am Chem Soc 115: 7772-7777.
40. Xiao B, Spencer J, Clements A, Ali-Khan N, Mittnacht S, Broceno C et al. (2003). Proc Natl Acad Sci USA 100: 2363-2368.
41. zur Hausen H. (1996). Biochim Biophys Acta 1288: F55-F78.
42. Zwahlen C, Legault P, Vincent SJF, Greenblatt J, Konrat R, Kay LE. (1997). J Am Chem Soc 119: 6711-6721.
43. Zwerschke W, Jansen-Durr P. (2000). Adv Cancer Res 78: 1-29.